欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2004, Vol. 9 ›› Issue (11): 1268-1272.

• 研究原著 • 上一篇    下一篇

异甘草素脂质体的制备及其对宫颈癌细胞体外增殖的抑制作用

张晶, 杨静, 吴基良1, 张琳, 詹春   

  1. 武汉大学医学院药理学系,武汉 430071,湖北;
    1咸宁医学院药学系,咸宁 437100,湖北
  • 收稿日期:2004-09-17 修回日期:2004-11-01 出版日期:2004-11-26 发布日期:2020-11-19
  • 通讯作者: 杨静,男,博士,副教授,硕士生导师,研究方向:分子药理与新药研究。Tel: 027-87331565 E-mail: yangjingliu@yahoo.com.cn
  • 作者简介:张晶,女,硕士研究生,研究方向:分子药理与新药研究。Tel: 027-87331875 E-mail: Jingjing900@163.net
  • 基金资助:
    湖北省科技攻关项目(No2004AA303B06)

Preparation of isoliquiritigenin liposome and its inhibitive effects on prolif-eration of human cervical cancer cells in vitro

ZHANG Jing, YANG Jing, WU Ji-Liang1, ZHANG Lin, ZHAN Chun   

  1. Department of Pharmacology, Medical College of Wuhan University, Wuhan 430071, Hubei, China;
    1Department of Pharmacy, Xianning College, Xianning 437100, Hubei, Chirm
  • Received:2004-09-17 Revised:2004-11-01 Online:2004-11-26 Published:2020-11-19

摘要: 目的: 研究异甘草素(ISL)脂质体对宫颈癌细胞体外增技的影响。方法: 采用超声波薄膜分散法制备ISL脂质体;葡聚糖凝肢层析法分离含药脂质体与游离药物并测定包封率;离心加速试验考察其稳定性;活细胞计数法测定生长曲线;MTT法测定细胞增殖。结果: ISL脂质体的平均粒径为233.1 nm,跨距为0.74,包封率为(70.8±2.5) %,稳定性好;ISL脂质体(5~80μmol·L-1)浓度依赖性地抑制宫颈癌细胞HeLa和SiHa细胞增殖,并呈时间依赖性,于d3达高峰,其抑制率最高分别为83.44%和96.14%;浓度依赖性(5~80 μmol·L-1)抑制 HeLa 和SiHa 增殖,ICW分别为 34.24 和 29.82 μmol·L-1 (ISL的 IC50分别为 75.39 和 69.33 μmol·L-1) 结论: 该制备工艺与处方可行,命制备的ISL脂质体对人宫颈癌细胞体外增殖有明显的抑制作用,且作用明显强于ISL。

关键词: ISL脂质体, 包封率, MTT法, SiHa细胞, HeLa细胞

Abstract: AIM: To study the effects of isoliquiritig-enin (ISL) liposome on the proliferation of human cervical cancer cells in vitro. METHODS: ISL liposome was prepared by filmultrasonic technique. The liposome and free ISL were separated by Sephadex G-25 exclusion chro-matography and the encapsulation rates were determined. The growth inhibitive effects on cell proliferation were evaluated by trypan blue exclusion and MTT method. RESULTS: The particle size of ISL liposome was 233.1 nm and the span was 0.74. The encapsulation rate was (70.83±2.5) % and the liposome was stable. ISL lipo-some (5-80μmol·L-1) inhibited the proliferation of hu-man cervical cancer cells in a concentration-and time-dependent manner, and the inhibitive rates of HeLa and SiHa cells reached the maximum at d 3 of culture (the maximum inhibitive rate was 83.44% and 96.14%). The IC50 of HeLa and SiHa cells which were exposed to ISL liposome for 48 h was 34.24 and 29.82 μmol·L-1, respectively, and which were exposed to free ISL for 48 h was 75,39 and 69.33 μmol·L-1, respectively. CONCLUSION: This formulation and technology are stable and practical. The ISL liposome can significantly inhibit the proliferation of human cervical cancer cells in vitro.

Key words: ISL liposome, encapsulation efficiency, MTT method, SiHa cells, HeLa cells

中图分类号: